Published in Arq Neuropsiquiatr on August 01, 2012
Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease. BMC Neurosci (2014) 0.80
Depressive symptoms in neurodegenerative diseases. World J Clin Cases (2015) 0.77
Detecting depression in Parkinson disease: A systematic review and meta-analysis. Neurology (2016) 0.77
Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson's disease. Front Cell Neurosci (2015) 0.76
Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review. J Clin Psychopharmacol (2016) 0.76
Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications. P T (2015) 0.75
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. P T (2015) 0.75
Analysis of pramipexole dose-response relationships in Parkinson's disease. Drug Des Devel Ther (2016) 0.75
Impulsive and Compulsive Behaviors in Parkinson Disease: The Norwegian ParkWest Study. J Parkinsons Dis (2016) 0.75
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease. J Neurol (2014) 0.75
Paroxysmal dystonia and neuromyelitis optica. Arq Neuropsiquiatr (2012) 1.47
Transcranial sonography as a diagnostic tool for Parkinson's disease: a pilot study in the city of Rio de Janeiro, Brazil. Arq Neuropsiquiatr (2011) 1.40
Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: a pilot study. Mol Pain (2012) 0.87
Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes. Dis Markers (2012) 0.83
Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients. Parkinsonism Relat Disord (2011) 0.83
Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson's disease. Dis Markers (2013) 0.82
The use of an antagonist 5-HT2a/c for depression and motor function in Parkinson' disease. Arq Neuropsiquiatr (2009) 0.81
Parkinsonism and AIDS: a clinical comparative study before and after HAART. Arq Neuropsiquiatr (2009) 0.80
Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease. Neurosci Lett (2010) 0.78
A study of LRRK2 mutations and Parkinson's disease in Brazil. Neurosci Lett (2007) 0.78
Can clinical tests detect early signs of monohemispheric brain tumors? J Neurol Phys Ther (2010) 0.77
Reply. Arq Neuropsiquiatr (2015) 0.75
Recurrent vocal fold paralysis and parsonage-turner syndrome. Case Rep Otolaryngol (2013) 0.75
Cortical myoclonus masquerading as spinal myoclonus. Mov Disord (2008) 0.75
Latin American consensus on guidelines for chronic migraine treatment. Arq Neuropsiquiatr (2013) 0.75
Progressive supranuclear palsy-like syndrome induced by amiodarone and flunarizine. Arq Neuropsiquiatr (2009) 0.75